ABOUT THIS STUDY
1. Males or females, 18 years of age or more; 2. Outpatients; 3. Major depressive disorder based on DSM-IV criteria, with/without current co-morbid anxiety disorder; 4. Has two or more episodes of depression (including the current episode) in the past 5 years, with an interval of at lease 2 months between the end of the previous episode and the beginning of the current episode. 5. The baseline score of 17-item Hamilton Rating Scale for Depression (HAM-D)>=17; 6 If female of childbearing potential, have a negative urine pregnancy test at baseline, if appropriate, and use a medically acceptable method of contraception throughout the study.
1.Hypersensitivity to venlafaxine;2.Received venlafaxine treatment
before;3.Clinically significant renal or hepatic disease or any other medical disease that,
in the opinion of the investigator, might compromise the study, including seizure disorder
(with the exception of a single childhood febrile seizure); 4.Alcohol or drug abuse within
the last year;5.A recent history of myocardial infarction or unstable heart disease (within
6 months of baseline);6.Bipolar disorder;7.For female, known or suspected pregnancy or
breast feeding;8.Use of a monoamine oxidize inhibitor (MAOI) within 14 days of baseline;
use of any investigational drug within 30 days of baseline.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Nashville, Tennessee
- Madison, Wisconsin
- Vancouver, British Columbia